Adicon Holdings Ltd
HKEX:9860
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
6.24
13.68
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Adicon Holdings Ltd
Total Equity
Adicon Holdings Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
A
|
Adicon Holdings Ltd
HKEX:9860
|
Total Equity
ÂĄ1.7B
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Total Equity
ÂĄ7.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
||
Topchoice Medical Co Inc
SSE:600763
|
Total Equity
ÂĄ3.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
18%
|
CAGR 10-Years
20%
|
||
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
Total Equity
ÂĄ17.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
28%
|
||
Dian Diagnostics Group Co Ltd
SZSE:300244
|
Total Equity
ÂĄ7.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
13%
|
CAGR 10-Years
28%
|
||
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Total Equity
ÂĄ7.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
36%
|
Adicon Holdings Ltd
Glance View
ADICON Holdings Ltd. engages in the provision of independent clinical laboratory services. The company is headquartered in Hangzhou, Zhejiang and currently employs 6,128 full-time employees. The company went IPO on 2023-06-30. The firm primarily provides testing services to hospitals, medical institutions, medical examination centers, consumers, pharmaceutical companies and contract research organizations (CROs). The firm's inspection services mainly include routine tests, esoteric tests, clinical immunologic testing, clinical chemistry testing, clinical molecular biology testing, pathology testing and others testing. The firm is also engaged in the sales of medical testing equipment. The firm principally conducts its businesses in the domestic market.
See Also
What is Adicon Holdings Ltd's Total Equity?
Total Equity
1.7B
CNY
Based on the financial report for Dec 31, 2023, Adicon Holdings Ltd's Total Equity amounts to 1.7B CNY.
What is Adicon Holdings Ltd's Total Equity growth rate?
Total Equity CAGR 3Y
19%
Over the last year, the Total Equity growth was 234%. The average annual Total Equity growth rates for Adicon Holdings Ltd have been 19% over the past three years .